Belite Bio (BLTE) Short Interest Ratio & Short Volume

Short interest is the volume of Belite Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 18,900 shares of BLTE short. Learn More on Belite Bio's current short interest.

Belite Bio saw a decrease in short interest in April. As of April 30th, there was short interest totaling 18,900 shares, a decrease of 44.4% from the previous total of 34,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Belite Bio: Prothena Co. plc (12.57%), Gyre Therapeutics, Inc. (0.54%), Ironwood Pharmaceuticals, Inc. (13.04%), Spyre Therapeutics, Inc. (12.81%), Pacira BioSciences, Inc. (7.74%), Ligand Pharmaceuticals Incorporated (4.49%), Mirum Pharmaceuticals, Inc. (18.04%), Collegium Pharmaceutical, Inc. (21.78%), MannKind Co. (13.21%), Verona Pharma plc (7.74%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling BLTE is an investing strategy that aims to generate trading profit from Belite Bio as its price is falling. BLTE shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Belite Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLTE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLTE, twice per month. The most recent reporting period available is April, 30 2024.